- Investing Ideas
- /
- Swiss Large Cap High Growth Potential
Swiss Large Cap High Growth Potential
UPDATED May 01, 2024
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
16 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
STMN | CHF123.00 | -10.3% | -13.1% | CHF19.6b | CHF138.67 | PE79.7x | E20.8% | 0.7% | Healthcare | ||
VACN | CHF462.70 | 0.9% | 46.4% | CHF13.9b | CHF456.31 | PE72.9x | E21.2% | 1.4% | Capital Goods | ||
SDZ | CHF31.15 | 1.8% | n/a | CHF13.4b | CHF34.99 | PE188.7x | E29.4% | 1.4% | Pharmaceuticals & Biotech | ||
BAER | CHF49.61 | 2.4% | -21.1% | CHF10.2b | CHF58.96 | PE22.4x | E21.0% | 5.2% | Diversified Financials | ||
SOON | CHF255.40 | 0.08% | -9.9% | CHF15.2b | CHF270.88 | PE25.4x | E10.7% | 1.8% | Healthcare | ||
SGSN | CHF81.06 | -1.1% | -0.1% | CHF15.3b | CHF88.13 | PE27.7x | E10.0% | 3.9% | Commercial Services | ||
SIKA | CHF263.30 | 1.5% | 7.7% | CHF42.2b | CHF293.76 | PE39.8x | E12.5% | 1.3% | Materials | ||
PGHN | CHF1,189.50 | -0.5% | 39.2% | CHF30.9b | CHF1,257.38 | PE30.8x | E13.9% | 3.3% | Diversified Financials | ||
ABBN | CHF44.89 | 0.8% | 40.1% | CHF83.0b | CHF41.86 | PE24.8x | E8.1% | 1.9% | Capital Goods | ||
NOVN | CHF89.05 | -0.08% | -3.7% | CHF181.7b | CHF99.70 | PE21.7x | E10.1% | 3.7% | Pharmaceuticals & Biotech | ||
LOGN | CHF72.06 | -0.2% | 30.1% | CHF11.1b | CHF76.49 | PE19.7x | E2.5% | 1.5% | Tech | ||
ROG | CHF220.60 | -0.7% | -21.5% | CHF178.0b | CHF279.06 | PE15.3x | E8.8% | 4.4% | Pharmaceuticals & Biotech | ||
EMSN | CHF737.00 | 3.0% | 2.4% | CHF17.2b | CHF664.29 | PE37.7x | E6.4% | 2.2% | Materials | ||
LONN | CHF510.40 | -2.4% | -12.3% | CHF36.8b | CHF566.00 | PE56.3x | E19.9% | 0.8% | Pharmaceuticals & Biotech | ||
ZURN | CHF444.20 | -0.5% | 3.7% | CHF64.0b | CHF462.29 | PE16x | E8.9% | 5.9% | Insurance | ||
ALC | CHF71.10 | -2.3% | 8.5% | CHF35.1b | CHF84.76 | PE39.1x | E10.5% | 0.3% | Healthcare |
Page 1 of 1